schliessen

Filtern

 

Bibliotheken

Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines

The tumor suppressor PTEN gene maps to chromosome 10q23.3 and encodes a dual specificity phosphatase. Mutations of this gene had been found in a variety of human tumors. In the present study, we analyzed the structure and expression of the PTEN gene in 34 hepatocellular carcinoma tissues and two hep... Full description

Journal Title: Molecular and Cellular Biochemistry 2004, Vol.262(1), pp.25-33
Main Author: Zhang, Lineng
Other Authors: Yu, Qiang , He, Jianyu , Zha, Xiliang
Format: Electronic Article Electronic Article
Language: English
Subjects:
FAK
ID: ISSN: 0300-8177 ; E-ISSN: 1573-4919 ; DOI: 10.1023/B:MCBI.0000038212.78008.7f
Link: http://dx.doi.org/10.1023/B:MCBI.0000038212.78008.7f
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: springer_jourMCBI.0000038212.78008.7f
title: Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines
format: Article
creator:
  • Zhang, Lineng
  • Yu, Qiang
  • He, Jianyu
  • Zha, Xiliang
subjects:
  • PTEN
  • mutation
  • expression
  • FAK
  • hepatocellular carcinoma
ispartof: Molecular and Cellular Biochemistry, 2004, Vol.262(1), pp.25-33
description: The tumor suppressor PTEN gene maps to chromosome 10q23.3 and encodes a dual specificity phosphatase. Mutations of this gene had been found in a variety of human tumors. In the present study, we analyzed the structure and expression of the PTEN gene in 34 hepatocellular carcinoma tissues and two hepatoma cell lines. We found neither homozygous nor hemizygous deletions in these samples. We, however, found point mutations in 4 of the 34 tissue samples. Five of ten hepatocellular carcinoma tissues showed reduced PTEN expression at mRNA level. HepG2 and SMMC-7721 hepatoma cells showed decreased PTEN expression at both mRNA and protein levels compared with immortalized L02 hepatic cells. PTEN mRNA in SMMC-7721 hepatoma cells could be reduced by TGF-βI treatment. We also found that the phosphorylation levels of FAK in both of the hepatoma cell lines were higher than that in L02 hepatic cells. Transient expression of the PTEN gene in SMMC-7721 and HepG2 hepatoma cells resulted in decreased FAK phosphorylation. The level of FAK tyrosine phosphorylation appeared to be inversely correlated with the level of the PTEN protein. In summary, our results indicated that the function of the PTEN gene in hepatocarcinomas may be impaired mainly through point mutations and expression deficiency and that the defect of PTEN in tumor cells could alter the phosphorylation of FAK. (Mol Cell Biochem 262: 25–33, 2004)
language: eng
source:
identifier: ISSN: 0300-8177 ; E-ISSN: 1573-4919 ; DOI: 10.1023/B:MCBI.0000038212.78008.7f
fulltext: fulltext
issn:
  • 1573-4919
  • 15734919
  • 0300-8177
  • 03008177
url: Link


@attributes
ID1158106313
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordidMCBI.0000038212.78008.7f
sourceidspringer_jour
recordidTN_springer_jourMCBI.0000038212.78008.7f
sourcesystemPC
pqid756247531
display
typearticle
titleStudy of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines
creatorZhang, Lineng ; Yu, Qiang ; He, Jianyu ; Zha, Xiliang
ispartofMolecular and Cellular Biochemistry, 2004, Vol.262(1), pp.25-33
identifier
subjectPTEN ; mutation ; expression ; FAK ; hepatocellular carcinoma
descriptionThe tumor suppressor PTEN gene maps to chromosome 10q23.3 and encodes a dual specificity phosphatase. Mutations of this gene had been found in a variety of human tumors. In the present study, we analyzed the structure and expression of the PTEN gene in 34 hepatocellular carcinoma tissues and two hepatoma cell lines. We found neither homozygous nor hemizygous deletions in these samples. We, however, found point mutations in 4 of the 34 tissue samples. Five of ten hepatocellular carcinoma tissues showed reduced PTEN expression at mRNA level. HepG2 and SMMC-7721 hepatoma cells showed decreased PTEN expression at both mRNA and protein levels compared with immortalized L02 hepatic cells. PTEN mRNA in SMMC-7721 hepatoma cells could be reduced by TGF-βI treatment. We also found that the phosphorylation levels of FAK in both of the hepatoma cell lines were higher than that in L02 hepatic cells. Transient expression of the PTEN gene in SMMC-7721 and HepG2 hepatoma cells resulted in decreased FAK phosphorylation. The level of FAK tyrosine phosphorylation appeared to be inversely correlated with the level of the PTEN protein. In summary, our results indicated that the function of the PTEN gene in hepatocarcinomas may be impaired mainly through point mutations and expression deficiency and that the defect of PTEN in tumor cells could alter the phosphorylation of FAK. (Mol Cell Biochem 262: 25–33, 2004)
languageeng
source
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://dx.doi.org/10.1023/B:MCBI.0000038212.78008.7f$$EView_full_text_in_Springer_(Subscribers_only)
search
creatorcontrib
0Zhang, Lineng
1Yu, Qiang
2He, Jianyu
3Zha, Xiliang
titleStudy of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines
descriptionThe tumor suppressor PTEN gene maps to chromosome 10q23.3 and encodes a dual specificity phosphatase. Mutations of this gene had been found in a variety of human tumors. In the present study, we analyzed the structure and expression of the PTEN gene in 34 hepatocellular carcinoma tissues and two hepatoma cell lines. We found neither homozygous nor hemizygous deletions in these samples. We, however, found point mutations in 4 of the 34 tissue samples. Five of ten hepatocellular carcinoma tissues showed reduced PTEN expression at mRNA level. HepG2 and SMMC-7721 hepatoma cells showed decreased PTEN expression at both mRNA and protein levels compared with immortalized L02 hepatic cells. PTEN mRNA in SMMC-7721 hepatoma cells could be reduced by TGF-βI treatment. We also found that the phosphorylation levels of FAK in both of the hepatoma cell lines were higher than that in L02 hepatic cells. Transient expression of the PTEN gene in SMMC-7721 and HepG2 hepatoma cells resulted in decreased FAK phosphorylation. The level of FAK tyrosine phosphorylation appeared to be inversely correlated with the level of the PTEN protein. In summary, our results indicated that the function of the PTEN gene in hepatocarcinomas may be impaired mainly through point mutations and expression deficiency and that the defect of PTEN in tumor cells could alter the phosphorylation of FAK. (Mol Cell Biochem 262: 25–33, 2004)
subject
0PTEN
1mutation
2expression
3FAK
4hepatocellular carcinoma
general
010.1023/B:MCBI.0000038212.78008.7f
1English
2Springer Science & Business Media B.V.
3SpringerLink
sourceidspringer_jour
recordidspringer_jourMCBI.0000038212.78008.7f
issn
01573-4919
115734919
20300-8177
303008177
rsrctypearticle
creationdate2004
addtitle
0Molecular and Cellular Biochemistry
1An International Journal for Chemical Biology in Health and Disease
2Mol Cell Biochem
searchscopespringer_journals_complete
scopespringer_journals_complete
lsr30VSR-Enriched:[pqid, issue, pages]
sort
titleStudy of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines
authorZhang, Lineng ; Yu, Qiang ; He, Jianyu ; Zha, Xiliang
creationdate20040700
facets
frbrgroupid6960407581007929501
frbrtype5
languageeng
creationdate2004
topic
0Pten
1Mutation
2Expression
3Fak
4Hepatocellular Carcinoma
collectionSpringerLink
prefilterarticles
rsrctypearticles
creatorcontrib
0Zhang, Lineng
1Yu, Qiang
2He, Jianyu
3Zha, Xiliang
jtitleMolecular And Cellular Biochemistry
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Zhang
1Yu
2He
3Zha
aufirst
0Lineng
1Qiang
2Jianyu
3Xiliang
au
0Zhang, Lineng
1Yu, Qiang
2He, Jianyu
3Zha, Xiliang
atitleStudy of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines
jtitleMolecular and Cellular Biochemistry
stitleMol Cell Biochem
addtitleAn International Journal for Chemical Biology in Health and Disease
risdate200407
volume262
issue1-2
spage25
epage33
issn0300-8177
eissn1573-4919
genrearticle
ristypeJOUR
abstractThe tumor suppressor PTEN gene maps to chromosome 10q23.3 and encodes a dual specificity phosphatase. Mutations of this gene had been found in a variety of human tumors. In the present study, we analyzed the structure and expression of the PTEN gene in 34 hepatocellular carcinoma tissues and two hepatoma cell lines. We found neither homozygous nor hemizygous deletions in these samples. We, however, found point mutations in 4 of the 34 tissue samples. Five of ten hepatocellular carcinoma tissues showed reduced PTEN expression at mRNA level. HepG2 and SMMC-7721 hepatoma cells showed decreased PTEN expression at both mRNA and protein levels compared with immortalized L02 hepatic cells. PTEN mRNA in SMMC-7721 hepatoma cells could be reduced by TGF-βI treatment. We also found that the phosphorylation levels of FAK in both of the hepatoma cell lines were higher than that in L02 hepatic cells. Transient expression of the PTEN gene in SMMC-7721 and HepG2 hepatoma cells resulted in decreased FAK phosphorylation. The level of FAK tyrosine phosphorylation appeared to be inversely correlated with the level of the PTEN protein. In summary, our results indicated that the function of the PTEN gene in hepatocarcinomas may be impaired mainly through point mutations and expression deficiency and that the defect of PTEN in tumor cells could alter the phosphorylation of FAK. (Mol Cell Biochem 262: 25–33, 2004)
copBoston
pubKluwer Academic Publishers
doi10.1023/B:MCBI.0000038212.78008.7f
pages25-33
date2004-07